摘要
目的观察康莱特注射液提高晚期癌症患者生存质量的作用。方法本组收集两家医院肿瘤科126例晚期癌症患者临床治疗资料,每位患者给予康莱特注射液100ml VDqd×20天,观察治疗后疼痛缓解,KPS变化,体重变化及不良反应。结果癌症疼痛缓解总有效率达76.99%(部分缓解60.32%,完全缓解16.67%),用药结束后疼痛缓解仍可维持2～6天;经康莱特治疗后91.27%(115126)的患者KPS评分提高,其中提高20以上达69.84%;未发现康莱特注射液对心、肝、肾功能方面的毒副作用。结论康莱特有明显提高晚期癌症患者的生存质量,且无明显毒副作用。
This study was carried out by clinical observation to evaluate the effect of Kanglaite injection on life quality improvement of patients with advanced cancer. The clinical observation of 126 cases of advanced cancer patients who received Kanglaite injection was completed on two hospitals. Each patient received Kanglaite injection at the dose of 100ml daily VD for 20 days.
The degree of pain relief, improvement of KtX3 and changes of weight were observed before and after treatment. The results indicated that the total cancer pain relief rate was 76.99% （PR 60.32% ＋ CR 16.67% ）. Analgesic effect might persist for 2 - 6 days after withdrawal of Kanglaite. 91.27% of the 126 advanced cancer patients had their KPS improved. No cardiac, liver or renal function damage were observed.
出处
《癌症进展》
2006年第3期262-265,共4页
Oncology Progress
关键词
康莱特
生存质量
Kanglaite injection life quality
